HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

15.200

-0.670-4.22%

Volume:2.77M

Turnover:42.77M

Market Cap:6.57B

PE:2.30K

High:16.050

Open:15.910

Low:15.190

Close:15.870

52wk High:48.800

52wk Low:14.820

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:0.68

T/O Rate:0.86%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:3.83

PE(LYR):2,303.03

PS:13.01

Loading ...

Overview Company News Filings

How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors

Simply Wall St.

CF PharmTech repurchases 20,000 H shares, treasury stock rises to 542,000

Bulletin Express

CF PHARMTECH (02652) Repurchases 20,000 Shares for HK$456,700 on April 2

CF PharmTech repurchases 9,500 H-shares; outstanding share count slips 0.0031%

Bulletin Express

CF PHARMTECH (02652) Spends HK$218,000 on Share Buyback on March 31

CF PharmTech's Profit Slumps in 2025

MT Newswires Live

CF PHARMTECH (02652) Announces Annual Results with Adjusted Profit of 31.75 Million Yuan, Advances Transition to Global Inhalation System Platform

CF Pharmtech FY25 profit drops 88.2% to RMB 2.5 million

CF PharmTech Flags Expected Decline in 2025 Profit

MT Newswires Live

CF PharmTech to Partner With JD Health on Product Launches

MT Newswires Live

CF PharmTech Signs Three-Year Strategic Partnership with JD Health for Exclusive Online Launch of Respiratory Portfolio

Bulletin Express

CF PHARMTECH (02652) Enters Strategic Partnership with JD HEALTH

CF PharmTech Taps JD Health as Exclusive Online Partner for New Respiratory Drugs

CF PharmTech signs strategic cooperation agreement with JD Health International Inc

CF Pharmtech Inc - JD Health to Be Exclusive Online Launch Platform for Major New Products for Three Years

THOMSON REUTERS

CF PHARMTECH (02652) Forecasts 2025 Adjusted Net Profit of RMB 30-35 Million, Highlights Steady Operations and R&D Progress

CF PharmTech issues profit warning: 2025 revenue projected to fall to RMB410-450 million, net profit to narrow to RMB2-3 million

Bulletin Express

CF Pharmtech - Expected Result Due Reduction in Average Selling Price of Group's Product CF017, Others in FY

THOMSON REUTERS

CF PharmTech forecasts 2025 revenue of RMB410 million to RMB450 million and net profit of RMB2 million to RMB3 million

CF PHARMTECH (02652) Schedules 30 March 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02652/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":15.2,"timestamp":1787299688006,"preClose":15.87,"halted":0,"volume":2773800,"delay":0,"changeRate":-0.04221802142407057,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Not Yet Opened","change":-0.67,"latestTime":"08-21 16:08:08","open":15.91,"high":16.05,"low":15.19,"amount":42769849,"amplitude":0.05419,"askPrice":15.3,"askSize":1800,"bidPrice":15.2,"bidSize":4600,"shortable":3,"etf":0,"ttmEps":0.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":15.87,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.6774718269660859,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":0.6774718269660859,"shares":432000000,"dividePrice":0,"high":16.05,"amplitude":0.05419,"preClose":15.87,"low":15.19,"week52Low":14.82,"pbRate":"3.83","psRate":"13.01","week52High":48.8,"institutionHeld":0,"latestPrice":15.2,"committee":0.4375,"eps":0.0066,"divideRate":0,"volume":2773800,"delay":0,"ttmEps":0.006,"open":15.91,"prevYearClose":35,"prevWeekClose":16.9,"prevMonthClose":19.87,"prevQuarterClose":21,"fiveDayClose":16.9,"twentyDayClose":15.76,"sixtyDayClose":19.66,"earningDate":1788105600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-08-21","current":2533.333333,"percent":0.556604,"low":-293.764894,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"high":3595.964728,"avg":1473.150348,"sd":1193.496335,"marketCap":6240837082},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082}],"updateTime":1787477576128},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625605898","title":"How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2625605898","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625605898?lang=en_us&edition=fundamental","pubTime":"2026-04-06 22:16","pubTimestamp":1775484997,"startTime":"0","endTime":"0","summary":"On March 20, 2026, CF PharmTech, Inc. announced a cooperation under which JD Health International will be the exclusive online launch platform for several major new respiratory and rhinology products over the next three years, while also exploring internet-based chronic disease management models together.\nAlongside this, JD Health’s recent grant of 834,412 new share awards with strict clawback terms and its deeper role in digital drug commercialization highlight how the company is tying...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/how-jd-healths-cf-pharmtech-alliance-and-equity-awards-strat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/how-jd-healths-cf-pharmtech-alliance-and-equity-awards-strat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4504","BK4579","BK4220","KJD","BK4531","02652","BK4551","BK4505","BK4526","BK4211","BK4588","BK1589","LU0106959298.USD","LU1188198961.HKD","09618","BK1583","HK0000320264.USD","BK1247","LU0051755006.USD","CHAT","LU1688375341.USD","BK1142","BK1591","SGXZ86797644.SGD","LU0307460666.USD","BK1615","BK4122","AGIX","HK0000306685.HKD","HK0000320223.HKD","LU0244354667.USD","SG9999002463.SGD","ARTY","BK4614","AIPO","BK1571","BK1515","HK0000306701.USD","BK4093","BK4524","LU0463099449.HKD","06618","BK4215","IE0008368742.USD","86618","SGXZ62798434.SGD","IE00BGV7N243.SGD","LU0326950275.SGD","LU0456827905.SGD","LU1880383366.USD","AI","BK4585","LU0588546209.SGD","BK4503","BK4509","BK4558"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186649255","title":"CF PharmTech repurchases 20,000 H shares, treasury stock rises to 542,000","url":"https://stock-news.laohu8.com/highlight/detail?id=1186649255","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186649255?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:43","pubTimestamp":1775126584,"startTime":"0","endTime":"0","summary":"On 2 April 2026, CF PharmTech, Inc. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange detailing the on-market buyback of 20,000 H shares. The shares were repurchased at prices...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111653616","title":"CF PHARMTECH (02652) Repurchases 20,000 Shares for HK$456,700 on April 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1111653616","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111653616?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:30","pubTimestamp":1775125813,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 2, the company repurchased 20,000 of its own shares at a total cost of approximately HK$456,700.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103936432","title":"CF PharmTech repurchases 9,500 H-shares; outstanding share count slips 0.0031%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103936432","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103936432?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:44","pubTimestamp":1774953888,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed a small-scale share buyback executed on 31 March 2026. The company repurchased 9,500 H-shares on the Hong Kong Stock Exchange at prices ranging between HK$22.90 and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134057733","title":"CF PHARMTECH (02652) Spends HK$218,000 on Share Buyback on March 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1134057733","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134057733?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:40","pubTimestamp":1774953636,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on March 31, 2026, the company repurchased 9,500 of its own shares at a total cost of HK$218,000.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318387","title":"CF PharmTech's Profit Slumps in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318387","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623318387?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:01","pubTimestamp":1774861313,"startTime":"0","endTime":"0","summary":"CF PharmTech's  profit attributable to owners of the parent fell to 2.5 million yuan for 2025 from 21.1 million yuan a year earlier, according to a Monday Hong Kong bourse filing.Earnings per share came in at 0.0066 yuan, compared with 0.0569 yuan a year earlier.Revenue declined to 432.5 million yuan from 607.8 million yuan in 2024.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CF","BK1191","BK4585","BK4588","02652","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135167999","title":"CF PHARMTECH (02652) Announces Annual Results with Adjusted Profit of 31.75 Million Yuan, Advances Transition to Global Inhalation System Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1135167999","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135167999?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:50","pubTimestamp":1774860646,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has released its annual results for the period ending December 31, 2025. The Group reported revenue of 433 million yuan (Renminbi), gross profit of 328 million yuan, profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623397797","title":"CF Pharmtech FY25 profit drops 88.2% to RMB 2.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397797","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623397797?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:32","pubTimestamp":1774859529,"startTime":"0","endTime":"0","summary":"CF PharmTech posted net income attributable to owners of RMB 2.5 million, down 88.22%.Gross margin narrowed 5.1 percentage points to 75.8% on lower CF017 pricing under VBP renewal and a mix shift toward lower-margin CF018.CF017 revenue dropped to RMB 340 million, while CF018 climbed to RMB 79 million; overseas revenue topped RMB 10 million, with cumulative overseas orders exceeding 16 million units.Management expects 2026 to be a year of resumed growth as CF017 procurement and execution normalize, supported by channel partnerships spanning primary care and online distribution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL4wY27L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621572163","title":"CF PharmTech Flags Expected Decline in 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2621572163","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621572163?lang=en_us&edition=fundamental","pubTime":"2026-03-23 12:44","pubTimestamp":1774241069,"startTime":"0","endTime":"0","summary":"CF PharmTech  said it expects 2 million yuan to 3 million yuan in attributable profit for 2025, down from 21.1 million yuan in 2024, according to a Hong Kong bourse filing Friday.Shares of the pharmaceutical firm fell nearly 2% in late morning trade Monday.The drop in profit comes amid an expected decline in revenue to 410 million yuan to 450 million yuan from 607.8 million yuan in 2024.The company's financial results are due by the end of March.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CF","BK1191","02652","BK4585","BK4588","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621287887","title":"CF PharmTech to Partner With JD Health on Product Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=2621287887","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621287887?lang=en_us&edition=fundamental","pubTime":"2026-03-23 09:45","pubTimestamp":1774230357,"startTime":"0","endTime":"0","summary":"CF PharmTech  is partnering with JD Health International  to launch a number of respiratory and rhinology therapeutic products, according to a Hong Kong bourse filing Monday.The firm said JD Health will serve as the exclusive online launch platform for a number of products over the next three years.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1188198961.HKD","BK4504","BK1615","LU0244354667.USD","SGXZ62798434.SGD","BK1191","BK1142","LU1688375341.USD","HK0000306701.USD","BK1583","BK4093","BK4579","06618","BK1515","BK1591","HK0000320264.USD","IE0008368742.USD","BK4524","BK4558","HK0000320223.HKD","LU0307460666.USD","BK4220","HK0000306685.HKD","LU0456827905.SGD","BK4585","BK4531","BK4526","86618","SGXZ86797644.SGD","BK4509","BK4614","LU0326950275.SGD","BK4503","BK4551","LU0106959298.USD","BK4505","LU0051755006.USD","02652","BK4588","BK4122","BK1589","LU1880383366.USD","BK1571","LU0588546209.SGD","IE00BGV7N243.SGD","BK1247","KJD","SG9999002463.SGD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185911468","title":"CF PharmTech Signs Three-Year Strategic Partnership with JD Health for Exclusive Online Launch of Respiratory Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1185911468","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185911468?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:21","pubTimestamp":1774225287,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (CF PharmTech) announced that it entered into a strategic cooperation agreement with JD Health International Inc. on 20 March 2026, appointing JD Health as the exclusive online...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167098882","title":"CF PHARMTECH (02652) Enters Strategic Partnership with JD HEALTH","url":"https://stock-news.laohu8.com/highlight/detail?id=1167098882","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167098882?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:18","pubTimestamp":1774225105,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced the formal signing of a strategic cooperation agreement with JD Health International Inc. (JD HEALTH) on March 20, 2026. Under this agreement, JD HEALTH will serve...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","BK1247","BK1615","BK1515","LU0051755006.USD","86618","BK1191","LU0456827905.SGD","02652","06618","SGXZ62798434.SGD","BK1583","BK1591","BK1589","SGXZ86797644.SGD","BK1571"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621956747","title":"CF PharmTech Taps JD Health as Exclusive Online Partner for New Respiratory Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2621956747","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621956747?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:07","pubTimestamp":1774224434,"startTime":"0","endTime":"0","summary":"CF PharmTech. Inc. Class H ( ($HK:2652) ) has shared an announcement. CF PharmTech, Inc., a PRC-based innovator in inhalation drug delivery, focuse...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cf-pharmtech-taps-jd-health-as-exclusive-online-partner-for-new-respiratory-drugs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cf-pharmtech-taps-jd-health-as-exclusive-online-partner-for-new-respiratory-drugs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KJD","BK4585","LU1880383366.USD","LU1188198961.HKD","BK4504","LU0307460666.USD","BK4579","BK4503","86618","LU0588546209.SGD","BK4614","09618","BK4524","BK4551","HK0000320223.HKD","BK4526","BK4093","LU0106959298.USD","LU0244354667.USD","BK4588","BK4122","HK0000306701.USD","IE00BGV7N243.SGD","BK4558","IE0008368742.USD","SG9999002463.SGD","02652","HK0000320264.USD","BK4531","BK4220","BK4509","LU0326950275.SGD","LU0463099449.HKD","LU1688375341.USD","HK0000306685.HKD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621747893","title":"CF PharmTech signs strategic cooperation agreement with JD Health International Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2621747893","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621747893?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:04","pubTimestamp":1774224298,"startTime":"0","endTime":"0","summary":"CF PharmTech signed a strategic cooperation agreement with JD Health on March 20, 2026.JD Health will act as the exclusive online launch platform for several new respiratory and rhinology products over the next three years.Support under the agreement includes online launch sales and patient services, plus prescription management and patient administration.The parties will also explore internet-based chronic disease management models.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL64hRqB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","02652","LU0868486357.SGD","LU1282649067.USD","SG9999002562.SGD","LU0348805143.USD","IE00B3M56506.USD","LU0384037296.USD","LU1794554557.SGD","LU1282649810.SGD","LU1366334651.USD","LU0051755006.USD","LU0314109678.HKD","LU0572944931.SGD","BK1502","LU0417516738.SGD","LU0828237510.HKD","LU1044876610.USD","LU1719994722.HKD","BK1610","LU0359202008.SGD","LU0048580855.USD","LU0231483743.USD","BK1142","BK1575","LU0348735423.USD","LU1303224171.USD","SG9999001226.SGD","LU2039709279.SGD","LU0531971595.HKD","BK1515","LU0543330483.HKD","LU0588545490.SGD","LU0488056044.USD","LU1044875133.USD","LU0708995583.HKD","LU0052750758.USD","LU0307460666.USD","LU0228367735.SGD","LU1813983027.USD","LU0359201612.USD","LU0140636845.USD","IE00B29SXG58.USD","89618","LU0084288322.USD","LU0163747925.USD","LU0499858602.USD","LU2242644610.SGD","LU0315179316.USD","LU0348825331.USD","LU0791591158.USD","LU1770036033.HKD","SGXZ62798434.SGD","BK1583","LU1770034418.SGD","LU0865486749.SGD","LU2257852520.SGD","BK1615","SGXZ86797644.SGD","JD","LU0456846285.SGD","LU1044874839.SGD","LU0345776255.USD","LU0029875118.USD","LU0128522157.USD","LU0469268626.HKD","LU0499858438.USD","LU0791590937.USD","LU0039217434.USD","LU0359201885.HKD","BK1619","LU0164880469.USD","LU0211977185.USD","LU0370786039.SGD","LU1282651121.HKD","LU0417516902.SGD","LU0456827905.SGD","LU1366334578.USD","LU0871576103.HKD","LU0588545904.SGD","LU1023057109.AUD","IE0032431581.USD","BK1249","LU0320764599.SGD","LU1224444064.USD","LU1251922891.USD","IE00BGV7N243.SGD","LU0315178854.USD","LU0293314216.USD","LU0650527681.SGD","LU0588545730.USD","LU0149721374.USD","LU0594300419.USD","LU1808992512.USD","SG9999002828.SGD","LU1282651048.USD","LU0588546209.SGD","LU0327786744.USD","LU0345775950.USD","LU0431992006.USD","LU0259732245.USD","LU0456842615.SGD","LU1481107354.HKD","BK1591","BK1247","LU1642822792.SGD","LU0672654166.SGD","LU1328277881.USD","LU0320764755.SGD","06618","BK1191","BK1571","BK1589","LU0164865239.USD","LU0228659784.USD","86618","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621747895","title":"CF Pharmtech Inc - JD Health to Be Exclusive Online Launch Platform for Major New Products for Three Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2621747895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621747895?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:04","pubTimestamp":1774224287,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40A030:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135163379","title":"CF PHARMTECH (02652) Forecasts 2025 Adjusted Net Profit of RMB 30-35 Million, Highlights Steady Operations and R&D Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1135163379","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135163379?lang=en_us&edition=fundamental","pubTime":"2026-03-21 00:42","pubTimestamp":1774024943,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that the Group's overall business operations remain normal, maintaining profitability for three consecutive years. The Group anticipates achieving the following for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108040015","title":"CF PharmTech issues profit warning: 2025 revenue projected to fall to RMB410-450 million, net profit to narrow to RMB2-3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1108040015","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108040015?lang=en_us&edition=fundamental","pubTime":"2026-03-20 22:43","pubTimestamp":1774017839,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. has warned shareholders that both revenue and earnings for the year ending 31 December 2025 will contract sharply, according to a preliminary review of unaudited management...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620732987","title":"CF Pharmtech - Expected Result Due Reduction in Average Selling Price of Group's Product CF017, Others in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2620732987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620732987?lang=en_us&edition=fundamental","pubTime":"2026-03-20 22:31","pubTimestamp":1774017062,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nFWN4080GK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620732629","title":"CF PharmTech forecasts 2025 revenue of RMB410 million to RMB450 million and net profit of RMB2 million to RMB3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620732629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620732629?lang=en_us&edition=fundamental","pubTime":"2026-03-20 22:30","pubTimestamp":1774017052,"startTime":"0","endTime":"0","summary":"CF Pharmtech expects revenue of RMB410 million to RMB450 million, compared with RMB607.75 million previously.Net profit attributable to shareholders is forecast at RMB2 million to RMB3 million under IFRS, versus RMB21.09 million previously.Adjusted net profit  is expected to be RMB30 million to RMB35 million, compared with RMB51.87 million previously.Key factors cited include a lower average selling price for CF017 after volume-based procurement renewal and higher R&D spending on innovative drugs.Additional factors cited include weaker demand linked to fewer respiratory infections and one-off listing expenses affecting IFRS net profit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL3L2JL7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174851335","title":"CF PHARMTECH (02652) Schedules 30 March 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1174851335","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174851335?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:42","pubTimestamp":1773823378,"startTime":"0","endTime":"0","summary":"CF PHARMTECH, Inc. (Stock Code: 02652) has set 30 March 2026 for a board meeting to review and approve the consolidated financial results for the fiscal year ended 31 December 2025. The agenda also...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":153,"code":"91000000","status":"200"}]}}